Early intervention with empirical antibacterials is essential in the treatment of ventilator-associated pneumonia | SpringerLink
JCM | Free Full-Text | Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia | HTML
Ventilator-Associated Pneumonia | SpringerLink
Invasive Ventilation Therapy - Armstrong Medical
Ventilator-associated pneumonia in the era of COVID-19 pandemic: How common and what is the impact? | Critical Care | Full Text
Downloads and Resources
ISO MDD to MDR Transition and Similarities Between ISO 13485:2016 and MDR | SGS
Ventilator Production
How I diagnose and manage ventilator-associated tracheobronchitis | Medicina Intensiva
How regulatory changes for medical devices sector are impacting manufacturers | The Financial Express
OES Medical to launch new ventilator at Arab Health - Med-Tech Innovation
Ventilator-associated pneumonia: A review of the clinically relevant challenges in diagnosis and prevention | BJMP.org
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia | European Respiratory Society
Microbiology of Ventilator-Associated Pneumonia | IntechOpen
Ventilator-associated pneumonia in patients with cancer: Impact of multidrug resistant bacteria
Levofloxacin in the treatment of ventilator-associated pneumonia - Clinical Microbiology and Infection
The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients | Critical Care | Full Text
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia | European Respiratory Society
JKMS :: Journal of Korean Medical Science
Update on ventilator-associated pneumonia | F1000Research
How medical industry regulation could impact ventilator shortage in the UK
Philips details plans to increase ventilator production - News | Philips
Use of Severity Scoring and Stratification Factors in Clinical Trials of Hospital-Acquired and Ventilator-Associated Pneumonia
Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin | SpringerLink
